The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: CORRECT Study of Minimal Residual Disease Detection in Colorectal Cancer
Official Title: CORRECT-MRD II: Second Colorectal Cancer Clinical Validation Study to Predict Recurrence Using a Circulating Tumor DNA Assay to Detect Minimal Residual Disease
Study ID: NCT05210283
Brief Summary: The CORRECT - MRD II study will prospectively enroll patients who have undergone complete surgical resection for stage II or III colorectal cancer. Patients will be followed for a minimum of 3 years and up to 5 years for recurrence.
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Providence Facey Medical Foundation, Mission Hills, California, United States
Torrance Memorial Medical Center, Torrance, California, United States
University of Florida, Gainesville, Florida, United States
Mount Sinai Medical - Comprehensive Cancer Center, Miami Beach, Florida, United States
Mid Florida Hematology and Oncology Center, Orange City, Florida, United States
Edwards Cancer Center, Elmhurst, Illinois, United States
Illinois Cancer Care, Peoria, Illinois, United States
Mercy Medical Center, Cedar Rapids, Iowa, United States
Medstar Franklin Square, Baltimore, Maryland, United States
Medstar Good Samaritan, Baltimore, Maryland, United States
Meritus Center for Clinical Research, Hagerstown, Maryland, United States
University of Maryland St. Joseph Medical Center, Towson, Maryland, United States
MMCORC - Metro Minnesota, Saint Louis Park, Minnesota, United States
Missouri Baptist Medical Center, Saint Louis, Missouri, United States
Levine Cancer Institute, Charlotte, North Carolina, United States
First Health of the Carolinas Cancer Center, Pinehurst, North Carolina, United States
Wake Forest Baptist Health, Winston-Salem, North Carolina, United States
Sanford NCORP of the North Central Plains, Fargo, North Dakota, United States
Columbus, Columbus, Ohio, United States
Kaiser Permanente Northwest, Portland, Oregon, United States
UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, United States
Reading Hospital, West Reading, Pennsylvania, United States
Lankenau Medical Center, Wynnewood, Pennsylvania, United States
WellSpan Health/York Cancer Center, York, Pennsylvania, United States
Primsa health Cancer Institute - Butternut, Greenville, South Carolina, United States
Sanford Cancer Center Oncology Clinic, Sioux Falls, South Dakota, United States
Ballad Health Cancer Care-Kingsport, Kingsport, Tennessee, United States
Marshfield Medical Center Weston, Weston, Wisconsin, United States
McGill University Health Centre-Cedars Cancer Centre, Montreal, Quebec, Canada